Product Images Alburx
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 2 images provide visual information about the product associated with Alburx NDC 44206-251 by Csl Behring Ag, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Albumin (Human) 25% Solution, brand name AlbuRx® 25, is a medicine for intravenous administration, manufactured by CSLBehring AG in Switzerland and distributed by CSLBehring LLC in the USA. The product contains 125g Albumin (Human) in 50 mL of buffered diluent and is stabilized with 0.02 M sodium caprylate and 0.02 M sodium N-acetyltryptophanate. The medicine is osmotically equivalent to 250 mL of plasma, with a Sodium content of 0.14 M. It is packed in a single-dose vial of 50 mL with complete directions for use. Patients and physicians should discuss the risks and benefits of this product. The package insert contains directions for use and product dosage information. It is essential to note that the medicine must not be used if it is turbid, and administration must not begin more than 4 hours after the container has been entered. Additionally, partially used vials should be discarded, and in cases of marked dehydration, additional fluids must accompany or follow the administration of albumin. The medicine contains no preservative and should be stored at room temperature not exceeding 30°C (86°F).*
This is a description of a medical product, specifically a 25% solution of Albumin (Human) called AlbuRx® 25, for intravenous administration. It comes in a 100 mL single-dose vial, and the package contains complete instructions for use. It is stabilized with 0.02 M sodium N-acetyltryptophanate and 0.02 M sodium caprylate and is osmotically equivalent to 500 mL of plasma. It contains no preservative and should not be used if turbid. Dehydration should be treated with additional fluids either before or after administering AlbuRx® 25. Patients and physicians should discuss the risks and benefits of using this product. It is manufactured by CSLBehring AG and distributed by CSL Behring LLC based in Kankakee, USA.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.